A 0 1 0 1 O
positive 2 10 2 10 O
Hepatitis 11 20 11 20 B-chronic_disease
B 21 22 21 22 I-chronic_disease
surface 23 30 23 30 O
antigen 31 38 31 38 O
test 39 43 39 43 O
result 44 50 44 50 O

ALT 0 3 51 54 B-clinical_variable
, 3 4 54 55 O
AST 5 8 56 59 B-clinical_variable
or 9 11 60 62 O
bilirubin 12 21 63 72 B-clinical_variable
≥ 22 23 73 74 O
1.5x 24 28 75 79 B-lower_bound
ULN 29 32 80 83 I-lower_bound
within 33 39 84 90 O
4 40 41 91 92 B-upper_bound
weeks 42 47 93 98 I-upper_bound
prior 48 53 99 104 I-upper_bound
to 54 56 105 107 O
baseline 57 65 108 116 O

Blood 0 5 117 122 B-treatment
transfusion 6 17 123 134 I-treatment
administered 18 30 135 147 O
within 31 37 148 154 O
4 38 39 155 156 B-upper_bound
weeks 40 45 157 162 I-upper_bound
prior 46 51 163 168 I-upper_bound
to 52 54 169 171 O
baseline 55 63 172 180 O

Cancer 0 6 181 187 B-cancer
patients 7 15 188 196 O
who 16 19 197 200 O
are 20 23 201 204 O
actively 24 32 205 213 O
undergoing 33 43 214 224 O
chemotherapy 44 56 225 237 B-treatment
at 57 59 238 240 O
screening 60 69 241 250 O
or 70 72 251 253 O
who 73 76 254 257 O
have 77 81 258 262 O
received 82 90 263 271 O
chemotherapy 91 103 272 284 O
within 104 110 285 291 O
3 111 112 292 293 B-upper_bound
months 113 119 294 300 I-upper_bound
prior 120 125 301 306 I-upper_bound
to 126 128 307 309 O
screening 129 138 310 319 O

Conditions 0 10 320 330 O
predisposing 11 23 331 343 O
to 24 26 344 346 O
an 27 29 347 349 O
increased 30 39 350 359 O
risk 40 44 360 364 O
of 45 47 365 367 O
serious 48 55 368 375 O
infection 56 65 376 385 B-chronic_disease
, 65 66 385 386 O
such 67 71 387 391 O
as 72 74 392 394 O
an 75 77 395 397 O
indwelling 78 88 398 408 O
vascular 89 97 409 417 O
catheter 98 106 418 426 O
( 107 108 427 428 O
central 108 115 428 435 O
venous 116 122 436 442 O
line 123 127 443 447 O
or 128 130 448 450 O
non 131 134 451 454 O
- 134 135 454 455 O
tunneled 135 143 455 463 O
/ 143 144 463 464 O
acute 144 149 464 469 O
hemodialysis 150 162 470 482 O
catheter 163 171 483 491 O
) 171 172 491 492 O
or 173 175 493 495 O
active 176 182 496 502 B-chronic_disease
infection 183 192 503 512 I-chronic_disease
requiring 193 202 513 522 O
antibiotic 203 213 523 533 B-treatment
therapy 214 221 534 541 I-treatment
at 222 224 542 544 O
any 225 228 545 548 O
time 229 233 549 553 O
during 234 240 554 560 O
the 241 244 561 564 O
2 245 246 565 566 B-lower_bound
weeks 247 252 567 572 I-lower_bound
prior 253 258 573 578 I-lower_bound
to 259 261 579 581 O
screening 262 271 582 591 O

Ferritin 0 8 592 600 B-clinical_variable
> 9 10 601 602 O
500 10 13 602 605 B-lower_bound
ng 14 16 606 608 I-lower_bound
/ 16 17 608 609 I-lower_bound
mL 17 19 609 611 I-lower_bound
and 20 23 612 615 O
≤ 24 25 616 617 O
2000 26 30 618 622 B-upper_bound
ng 31 33 623 625 I-upper_bound
/ 33 34 625 626 I-upper_bound
mL 34 36 626 628 I-upper_bound
at 37 39 629 631 O
screening 40 49 632 641 O

Hemodialysis 0 12 642 654 B-treatment
- 12 13 654 655 O
dependent 13 22 655 664 O
for 23 26 665 668 O
at 27 29 669 671 O
least 30 35 672 677 O
2 36 37 678 679 B-lower_bound
months 38 44 680 686 I-lower_bound
prior 45 50 687 692 I-lower_bound
to 51 53 693 695 O
screening 54 63 696 705 O

Hemoglobin 0 10 706 716 B-clinical_variable
( 11 12 717 718 I-clinical_variable
Hgb 12 15 718 721 I-clinical_variable
) 15 16 721 722 I-clinical_variable
≥ 17 18 723 724 O
8.5 19 22 725 728 B-lower_bound
and 23 26 729 732 O
< 27 28 733 734 O
11.5 29 33 735 739 B-upper_bound
g 34 35 740 741 I-upper_bound
/ 35 36 741 742 I-upper_bound
dL 36 38 742 744 I-upper_bound
at 39 41 745 747 O
screening 42 51 748 757 O

Known 0 5 758 763 O
diagnosis 6 15 764 773 O
of 16 18 774 776 O
hemochromatosis 19 34 777 792 B-chronic_disease
, 34 35 792 793 O
bone 36 40 794 798 B-cancer
marrow 41 47 799 805 I-cancer
malignancy 48 58 806 816 I-cancer
, 58 59 816 817 O
lymphatic 60 69 818 827 B-cancer
malignancy 70 80 828 838 I-cancer
or 81 83 839 841 O
myelodysplastic 84 99 842 857 B-cancer
syndrome 100 108 858 866 I-cancer

Liver 0 5 867 872 B-chronic_disease
disease 6 13 873 880 I-chronic_disease
/ 13 14 880 881 O
dysfunction 14 25 881 892 B-chronic_disease
( 26 27 893 894 O
Child 27 32 894 899 B-clinical_variable
- 32 33 899 900 I-clinical_variable
Pugh 33 37 900 904 I-clinical_variable
score 38 43 905 910 I-clinical_variable
≥ 44 45 911 912 O
6 46 47 913 914 B-lower_bound
) 47 48 914 915 O
, 48 49 915 916 O
prior 50 55 917 922 B-treatment
liver 56 61 923 928 I-treatment
transplant 62 72 929 939 I-treatment
, 72 73 939 940 O
heart 74 79 941 946 B-treatment
failure 80 87 947 954 I-treatment
( 88 89 955 956 O
NYHA 89 93 956 960 O
Class 94 99 961 966 O
III 100 103 967 970 O
or 104 106 971 973 O
IV 107 109 974 976 O
) 109 110 976 977 O
; 110 111 977 978 O
gastrointestinal 112 128 979 995 B-chronic_disease
bleeding 129 137 996 1004 I-chronic_disease

Patients 0 8 1005 1013 O
who 9 12 1014 1017 O
received 13 21 1018 1026 O
CSJ137 22 28 1027 1033 B-treatment
dose 29 33 1034 1038 O
in 34 36 1039 1041 O
the 37 40 1042 1045 O
pas 41 44 1046 1049 O

Patients 0 8 1050 1058 O
with 9 13 1059 1063 O
Hepatitis 14 23 1064 1073 B-chronic_disease
C 24 25 1074 1075 I-chronic_disease
Virus 26 31 1076 1081 I-chronic_disease
( 32 33 1082 1083 I-chronic_disease
HCV 33 36 1083 1086 I-chronic_disease
) 36 37 1086 1087 I-chronic_disease
infection 38 47 1088 1097 O
may 48 51 1098 1101 O
be 52 54 1102 1104 O
included 55 63 1105 1113 O
if 64 66 1114 1116 O
all 67 70 1117 1120 O
other 71 76 1121 1126 O
liver 77 82 1127 1132 O
function 83 91 1133 1141 O
eligibility 92 103 1142 1153 O
criteria 104 112 1154 1162 O
are 113 116 1163 1166 O
met 117 120 1167 1170 O

Receiving 0 9 1171 1180 O
erythropoietin 10 24 1181 1195 B-treatment
( 25 26 1196 1197 I-treatment
EPO 26 29 1197 1200 I-treatment
) 29 30 1200 1201 I-treatment
therapy 31 38 1202 1209 I-treatment

Receiving 0 9 1210 1219 O
hemodialysis 10 22 1220 1232 B-treatment
at 23 25 1233 1235 O
least 26 31 1236 1241 O
2 32 33 1242 1243 B-lower_bound
times 34 39 1244 1249 O
per 40 43 1250 1253 O
week 44 48 1254 1258 O

TSAT 0 4 1259 1263 B-clinical_variable
≤ 5 6 1264 1265 O
50 7 9 1266 1268 B-upper_bound
% 9 10 1268 1269 I-upper_bound
at 11 13 1270 1272 O
a 14 15 1273 1274 O
minimum 16 23 1275 1282 O
of 24 26 1283 1285 O
one 27 30 1286 1289 O
time 31 35 1290 1294 O
point 36 41 1295 1300 O
during 42 48 1301 1307 O
the 49 52 1308 1311 O
90 53 55 1312 1314 B-upper_bound
days 56 60 1315 1319 I-upper_bound
prior 61 66 1320 1325 I-upper_bound
to 67 69 1326 1328 O
baseline 70 78 1329 1337 O

Tunneled 0 8 1338 1346 B-treatment
hemodialysis 9 21 1347 1359 I-treatment
catheters 22 31 1360 1369 I-treatment
, 31 32 1369 1370 O
and 33 36 1371 1374 O
other 37 42 1375 1380 O
permanent 43 52 1381 1390 O
catheters 53 62 1391 1400 O
are 63 66 1401 1404 O
permitted 67 76 1405 1414 O

Uncontrolled 0 12 1415 1427 O
renal 13 18 1428 1433 B-chronic_disease
osteodystrophy 19 33 1434 1448 I-chronic_disease
defined 34 41 1449 1456 O
asthe 42 47 1457 1462 O
coexistence 48 59 1463 1474 O
of 60 62 1475 1477 O
all 63 66 1478 1481 O
of 67 69 1482 1484 O
the 70 73 1485 1488 O
following 74 83 1489 1498 O
at 84 86 1499 1501 O
screening 87 96 1502 1511 O
( 97 98 1512 1513 O
1 98 99 1513 1514 O
) 99 100 1514 1515 O
intact 101 107 1516 1522 B-clinical_variable
PTH 108 111 1523 1526 I-clinical_variable
≥ 112 113 1527 1528 O
750 114 117 1529 1532 B-lower_bound
pg 118 120 1533 1535 I-lower_bound
/ 120 121 1535 1536 I-lower_bound
mL 121 123 1536 1538 I-lower_bound
, 123 124 1538 1539 O
( 125 126 1540 1541 O
2 126 127 1541 1542 O
) 127 128 1542 1543 O
serum 129 134 1544 1549 O
phosphate 135 144 1550 1559 O
above 145 150 1560 1565 O
the 151 154 1566 1569 O
upper 155 160 1570 1575 O
limit 161 166 1576 1581 O
of 167 169 1582 1584 O
the 170 173 1585 1588 O
lab 174 177 1589 1592 O
normal 178 184 1593 1599 O
range 185 190 1600 1605 O
, 190 191 1605 1606 O
and 192 195 1607 1610 O
( 196 197 1611 1612 O
3 197 198 1612 1613 O
) 198 199 1613 1614 O
calcium 200 207 1615 1622 B-clinical_variable
x 208 209 1623 1624 I-clinical_variable
phosphate 210 219 1625 1634 I-clinical_variable
product 220 227 1635 1642 I-clinical_variable
> 228 229 1643 1644 O
75 230 232 1645 1647 B-lower_bound
mg2 233 236 1648 1651 I-lower_bound
/ 236 237 1651 1652 I-lower_bound
dL2 237 240 1652 1655 I-lower_bound
( 241 242 1656 1657 O
6.05 242 246 1657 1661 B-lower_bound
mmol2 247 252 1662 1667 I-lower_bound
/ 252 253 1667 1668 I-lower_bound
L2 253 255 1668 1670 I-lower_bound
) 255 256 1670 1671 O

istory 0 6 1672 1678 O
of 7 9 1679 1681 O
dialysis 10 18 1682 1690 B-treatment
AV 19 21 1691 1693 B-chronic_disease
fistula 22 29 1694 1701 I-chronic_disease
thrombosis 30 40 1702 1712 I-chronic_disease
within 41 47 1713 1719 O
2 48 49 1720 1721 B-upper_bound
months 50 56 1722 1728 I-upper_bound
prior 57 62 1729 1734 I-upper_bound
to 63 65 1735 1737 O
screening 66 75 1738 1747 O
, 75 76 1747 1748 O
or 77 79 1749 1751 O
2 80 81 1752 1753 O
or 82 84 1754 1756 O
more 85 89 1757 1761 O
episodes 90 98 1762 1770 O
of 99 101 1771 1773 O
AV 102 104 1774 1776 O
fistula 105 112 1777 1784 O
thrombosis 113 123 1785 1795 O
within 124 130 1796 1802 O
6 131 132 1803 1804 B-upper_bound
months 133 139 1805 1811 I-upper_bound
prior 140 145 1812 1817 I-upper_bound
to 146 148 1818 1820 O
screening 149 158 1821 1830 O

